| Source publication date | (updated; first published 2022-11-29) |
|---|---|
| Reported on Testosterone Science | |
| Outlet type | Testosterone and hormone clinic or telehealth website |
| Population | Men and women |
| Source | LifeMD |
| URL | lifemd.com/learn/hormone-replacement-therapy-and-weight-loss-what-should-i-know (opens in a new tab) |
Specific Claim Evaluated
Testosterone may be prescribed in hormone replacement therapy because it aids fat loss, and expected benefits of therapy include weight loss and reduced body fat, especially belly fat.
Primary Research Supporting or Contradicting the Claim
A meta-analysis of randomized trials in women found that testosterone improved sexual function in postmenopausal women and was associated with an increase in weight (Islam et al., 2019). The global consensus statement finds insufficient evidence for testosterone use in women for any indication other than hypoactive sexual desire disorder (Davis et al., 2019).
Corrected Evidence-Based Interpretation
Testosterone is not a weight-loss treatment. In women, randomized evidence shows weight gain rather than loss, and in men testosterone alters body composition modestly without being indicated for weight reduction.
Rationale for Grade
The page presents weight and fat loss as an expected benefit of hormone therapy that includes testosterone, with no supporting citation. This reverses the direction of the randomized evidence in women and presents a body composition effect in men as weight loss.
References
- Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L, Wierman ME. Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab. 2019;104(10):4660-4666. PMID
Supporting excerpt: "The only evidence-based indication for testosterone for women is for HSDD." - Islam RM, Bell RJ, Green S, Page MJ, Davis SR. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol. 2019;7(10):754-766. PMID
Supporting excerpt: "Testosterone is effective for postmenopausal women with low sexual desire causing distress"